389 related articles for article (PubMed ID: 21902653)
1. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
Smolewski P; Robak T
Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
3. [The role of the inhibitor of apoptosis protein (IAP) family in hematological malignancies].
Grzybowska-Izydorczyk O; Smolewski P
Postepy Hig Med Dosw (Online); 2008 Feb; 62():55-63. PubMed ID: 18283236
[TBL] [Abstract][Full Text] [Related]
4. Targeting the inhibitor of Apoptosis Protein BIR3 binding domains.
Jaquith JB
Pharm Pat Anal; 2014 May; 3(3):297-312. PubMed ID: 24998289
[TBL] [Abstract][Full Text] [Related]
5. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
[TBL] [Abstract][Full Text] [Related]
6. Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin.
Coyle R; O'Sullivan MJ; Zisterer DM
Cancer Treat Res Commun; 2022; 32():100579. PubMed ID: 35613525
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of apoptosis proteins in hematological malignancies.
Fulda S
Leukemia; 2009 Mar; 23(3):467-76. PubMed ID: 19039324
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemia.
Grzybowska-Izydorczyk O; Cebula B; Robak T; Smolewski P
Eur J Cancer; 2010 Mar; 46(4):800-10. PubMed ID: 20045309
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
12. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
[TBL] [Abstract][Full Text] [Related]
13. A Pan-Cancer Analysis of the BIRC Gene Family and Its Association with Prognosis, Tumor Microenvironment, and Therapeutic Targets.
Wu S; Zang Q; Xing Z; Li X; Leng J; Liu Y; Wang X; Yang J
Crit Rev Eukaryot Gene Expr; 2021; 31(4):35-48. PubMed ID: 34587434
[TBL] [Abstract][Full Text] [Related]
14. The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.
Cheung HH; Plenchette S; Kern CJ; Mahoney DJ; Korneluk RG
Mol Biol Cell; 2008 Jul; 19(7):2729-40. PubMed ID: 18434593
[TBL] [Abstract][Full Text] [Related]
15. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
[TBL] [Abstract][Full Text] [Related]
16. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
[TBL] [Abstract][Full Text] [Related]
17. The inhibitor of apoptosis protein family and its antagonists in acute leukemias.
Wrzesień-Kuś A; Smolewski P; Sobczak-Pluta A; Wierzbowska A; Robak T
Apoptosis; 2004 Nov; 9(6):705-15. PubMed ID: 15505413
[TBL] [Abstract][Full Text] [Related]
18. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
Fulda S
Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
[TBL] [Abstract][Full Text] [Related]
19. The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.
Luk SU; Xue H; Cheng H; Lin D; Gout PW; Fazli L; Collins CC; Gleave ME; Wang Y
Oncotarget; 2014 Aug; 5(16):6896-908. PubMed ID: 25071009
[TBL] [Abstract][Full Text] [Related]
20. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
